VJOncology is committed to improving our service to you

ESMO Breast 2020 | CLEOPATRA & EMILIA: HER2+ mBC state-of-the-art

VJOncology is committed to improving our service to you

Sandra Swain

Sandra Swain, MD, FACP, Georgetown University Medical Center, Washington, DC, discusses the current state-of-the-art in treating HER2+ metastatic breast cancer (mBC) drawing on data from the CLEOPATRA (NCT00567190) and EMILIA (NCT00829166) trials. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter